Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
82 studies found for:    Vaginitis: Clinical Trials
Show Display Options
RSS Create an RSS feed from your search for:
Vaginitis: Clinical Trials
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms
Conditions: Menopause;   Postmenopausal Vaginal Atrophy
Intervention: Drug: estradiol, 10 mcg
2 Completed A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis
Condition: Atrophic Vaginitis
Interventions: Drug: Estradiol Vaginal Cream, 0.01%;   Drug: Estrace® 0.01% cream;   Drug: Placebo Vaginal Cream
3 Terminated
Has Results
A Trial to Evaluate the Efficacy of Low Dose Vaginal Estrogens in the Treatment of Atrophic Vaginitis
Condition: Atrophic Vaginitis
Interventions: Drug: Estriol;   Drug: Estradiol valerate;   Drug: Vanicream Lite
4 Completed Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible Microbicide
Conditions: HIV Infections;   Chlamydia Trachomatis;   Neisseria Gonorrhoeae;   Trichomonas Vaginitis;   Syphilis;   Herpes Simplex
Intervention: Drug: Carraguard (PC-515)
5 Completed Evaluation of Safety and Efficacy of 17-Beta Estradiol in Treatment of Atrophic Vaginitis: An Extension Trial
Conditions: Menopause;   Postmenopausal Vaginal Atrophy
Intervention: Drug: estradiol, 25 mcg
6 Unknown  Effect of Omega 3 on Atrophic Vaginitis in Breast Cancer Survivors
Conditions: Ductal Breast Carcinoma in Situ;   Breast Cancer, Stage I;   Breast Cancer, Stage II;   Breast Cancer, Stage III
Interventions: Dietary Supplement: omega-3 fatty acid;   Other: placebo;   Behavioral: Questionnaire administration
7 Completed Comparison of Two Vaginal Tablets, Produced at Different Sites, in Postmenopausal Women With Atrophic Vaginitis
Conditions: Menopause;   Postmenopausal Vaginal Atrophy
Intervention: Drug: estradiol, 25 mcg
8 Recruiting Comparison of Vaginal Laser Therapy to Vaginal Estrogen Therapy
Conditions: Atrophic Vaginitis;   Menopause
Interventions: Device: CO2 fractionated vaginal laser;   Drug: Estrogens, Conjugated (USP)
9 Not yet recruiting Vaginal and Urinary Microbiome Trial
Conditions: Atrophic Vaginitis;   Menopause;   Recurrent Urinary Tract Infections
Interventions: Drug: Premarin vaginal cream;   Drug: Apricot kernel oil
10 Completed Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI Transmission
Conditions: HIV Infections;   Chlamydia Trachomatis;   Neisseria Gonorrhoeae;   Trichomonas Vaginitis;   Syphilis
Intervention: Drug: Carraguard (PC-515)
11 Completed
Has Results
Endometrial Safety of a Low Dose of Vagifem® in Postmenopausal Women With Atrophic Vaginitis
Conditions: Menopause;   Postmenopausal Vaginal Atrophy
Intervention: Drug: estradiol, 10 mcg
12 Completed Study of the Management of Vaginal Discharge in West African Using Single Dose Treatments
Conditions: Bacterial Vaginosis;   Candidiasis;   Vaginitis
Intervention: Drug: tinidazole+fluconazole vs metronidazole+clotrimazole
13 Not yet recruiting Vaginal Progesterone Versus Placebo for the Treatment of Vaginal Atrophy
Conditions: Atrophic Vaginitis;   Menopause;   Vulvovaginal Atrophy
Intervention: Drug: Vaginal progesterone
14 Unknown  Saginil in vs. Placebo for Gynecologic Oncology Patients Affected by Vaginitis
Condition: Vaginitis
Interventions: Drug: Adelmidrol vaginal gel;   Drug: Placebo vaginal gel
15 Unknown  Accuracy and Acceptability of Self-Diagnostic Methods for Vaginitis in Adolescent Females
Condition: Trichomonas Vaginalis
Intervention: Device: Point of care tests
16 Active, not recruiting Assessment of the Efficacy of POLYGYNAX® in the Empirical Treatment of Infectious Vaginitis
Condition: Vaginitis
Interventions: Drug: POLYGYNAX®;   Drug: GYNODAKTARIN®;   Drug: Placebo
17 Completed Vaginal Infection Study
Conditions: Vulvovaginitis;   Vaginitis
Interventions: Drug: clindamycin phosphate/butoconazole nitrate;   Drug: clindamycin phosphate;   Drug: butoconazole nitrate
18 Completed
Has Results
A Study to Compare Efficacy and Safety of an Ovule Containing Terconazole, Clindamycin and Fluocinolone Versus an Ovule Containing Metronidazole, Nystatin and Fluocinolone in the Treatment of Secondary Vulvar/ or Vaginal Symptoms of Infectious Vaginitis/ and Infectious Vaginosis
Conditions: Vaginitis;   Infectious Vaginosis
Interventions: Drug: Gynoclin V;   Drug: Vagitrol V
19 Enrolling by invitation Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
Conditions: Candidiasis, Vulvovaginal;   Yeast Infection;   Mycoses;   Moniliasis, Vulvovaginal;   Vaginitis, Monilial
Intervention:
20 Completed Pharmacokinetic Assessment of the Absorption of Estradiol in Postmenopausal Women With Atrophic Vaginitis
Conditions: Menopause;   Postmenopausal Vaginal Atrophy
Interventions: Drug: estradiol, 10 mcg;   Drug: estradiol, 25 mcg

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years